Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Gabelle

Showing results (91-100 of 171) with videos related to

Pageof 18
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2025
Impact of preanalytical delay on the performance of plasma Aβ42, Aβ42/40, p-tau217, and p-tau217/Aβ42 in detecting brain amyloidosis in the ALZAN cohortConstance Delaby, Audrey Gabelle, Marie Duchiron, et al.
Scientific Reports|March 3, 2018
Author Correction: Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substratesFernando Bartolome, Noemi Esteras, Angeles Martin-Requero, et al.
Ebiomedicine|June 13, 2025
Comparative performance of plasma pTau181/Aβ42, pTau217/Aβ42 ratios, and individual measurements in detecting brain amyloidosisSylvain Lehmann, Audrey Gabelle, Marie Duchiron, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
The ratio of plasma pTau217 to Aβ42 outperforms individual measurements in detecting brain amyloidosisSylvain Lehmann, Audrey Gabelle, Marie Duchiron, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 3, 2021
Investigating the association between cancer and the risk of dementia: Results from the Memento cohortJonviea D Chamberlain, Anaïs Rouanet, Bruno Dubois, et al.
Scientific Reports|May 12, 2017
Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substratesFernando Bartolome, Noemi Esteras, Angeles Martin-Requero, et al.
Journal of Proteomics|September 1, 2017
Towards a routine application of Top-Down approaches for label-free discovery workflowsPierre-Olivier Schmit, Jerome Vialaret, Hans J C T Wessels, et al.
Environment International|January 23, 2021
Long-term exposure to ambient air pollution and risk of dementia: Results of the prospective Three-City StudyMarion Mortamais, Laure-Anne Gutierrez, Kees de Hoogh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentMarwan N Sabbagh, Audrey Gabelle, Timo Grimmer, et al.
Molecular Psychiatry|January 16, 2024
Monitoring synaptic pathology in Alzheimer's disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectivesSimone Lista, Alejandro Santos-Lozano, Enzo Emanuele, et al.
Pageof 18

Showing results (91-100 of 171) with videos related to

Sort By:
Pageof 18
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2025
Impact of preanalytical delay on the performance of plasma Aβ42, Aβ42/40, p-tau217, and p-tau217/Aβ42 in detecting brain amyloidosis in the ALZAN cohortConstance Delaby, Audrey Gabelle, Marie Duchiron, et al.
Scientific Reports|March 3, 2018
Author Correction: Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substratesFernando Bartolome, Noemi Esteras, Angeles Martin-Requero, et al.
Ebiomedicine|June 13, 2025
Comparative performance of plasma pTau181/Aβ42, pTau217/Aβ42 ratios, and individual measurements in detecting brain amyloidosisSylvain Lehmann, Audrey Gabelle, Marie Duchiron, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
The ratio of plasma pTau217 to Aβ42 outperforms individual measurements in detecting brain amyloidosisSylvain Lehmann, Audrey Gabelle, Marie Duchiron, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 3, 2021
Investigating the association between cancer and the risk of dementia: Results from the Memento cohortJonviea D Chamberlain, Anaïs Rouanet, Bruno Dubois, et al.
Scientific Reports|May 12, 2017
Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substratesFernando Bartolome, Noemi Esteras, Angeles Martin-Requero, et al.
Journal of Proteomics|September 1, 2017
Towards a routine application of Top-Down approaches for label-free discovery workflowsPierre-Olivier Schmit, Jerome Vialaret, Hans J C T Wessels, et al.
Environment International|January 23, 2021
Long-term exposure to ambient air pollution and risk of dementia: Results of the prospective Three-City StudyMarion Mortamais, Laure-Anne Gutierrez, Kees de Hoogh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentMarwan N Sabbagh, Audrey Gabelle, Timo Grimmer, et al.
Molecular Psychiatry|January 16, 2024
Monitoring synaptic pathology in Alzheimer's disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectivesSimone Lista, Alejandro Santos-Lozano, Enzo Emanuele, et al.
Pageof 18